Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial

[1]  Pedro Alonso,et al.  Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials , 2009, The Lancet.

[2]  D. Chandramohan,et al.  High Resistance of Plasmodium falciparum to Sulphadoxine/Pyrimethamine in Northern Tanzania and the Emergence of dhps Resistance Mutation at Codon 581 , 2009, PloS one.

[3]  O. Toure,et al.  Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali , 2008, Malaria Journal.

[4]  S. Owusu-Agyei,et al.  Duration of Protection against Malaria and Anaemia Provided by Intermittent Preventive Treatment in Infants in Navrongo, Ghana , 2008, PloS one.

[5]  R. Snow,et al.  Evidence for Over-Dispersion in the Distribution of Clinical Malaria Episodes in Children , 2008, PloS one.

[6]  B. Cissé,et al.  A Trial of the Efficacy, Safety and Impact on Drug Resistance of Four Drug Regimens for Seasonal Intermittent Preventive Treatment for Malaria in Senegalese Children , 2008, PloS one.

[7]  R. Newman,et al.  Intermittent preventive therapy for malaria: progress and future directions , 2007, Current opinion in infectious diseases.

[8]  S. Agnandji,et al.  Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial. , 2007, The Journal of infectious diseases.

[9]  K. Reither,et al.  Intermittent Preventive Treatment in Infants as a Means of Malaria Control: a Randomized, Double-Blind, Placebo-Controlled Trial in Northern Ghana , 2007, Antimicrobial Agents and Chemotherapy.

[10]  S. Adjei,et al.  A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  C. Menéndez,et al.  Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. , 2006, The Journal of infectious diseases.

[12]  F. Nosten,et al.  Population Pharmacokinetic Assessment of a New Regimen of Mefloquine Used in Combination Treatment of Uncomplicated Falciparum Malaria , 2006, Antimicrobial Agents and Chemotherapy.

[13]  B. Cissé,et al.  Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial , 2006, The Lancet.

[14]  S. Jaffar,et al.  Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana , 2005, BMJ : British Medical Journal.

[15]  M. Tanner,et al.  Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial , 2005, The Lancet.

[16]  N. White.  Open access, freely available online Policy Forum Intermittent Presumptive Treatment for Malaria A better understanding of the pharmacodynamics will guide more rational policymaking , 2022 .

[17]  B. Sharp,et al.  Intercontinental Spread of Pyrimethamine-Resistant Malaria , 2004, Science.

[18]  C. Curtis,et al.  Variation of malaria transmission and morbidity with altitude in Tanzania and with introduction of alphacypermethrin treated nets , 2003, Malaria Journal.

[19]  T. Theander,et al.  Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial , 2003, The Lancet.

[20]  M. Tanner,et al.  Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial , 2001, The Lancet.

[21]  R. Price,et al.  Population pharmacokinetics of mefloquine in patients with acute falciparum malaria , 1999, Clinical pharmacology and therapeutics.

[22]  C. Curtis,et al.  Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone. , 1997, Acta tropica.

[23]  R. Price,et al.  Mefloquine in infants and young children. , 1996, Annals of tropical paediatrics.

[24]  W. Wernsdorfer,et al.  High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[25]  S. Rutstein,et al.  Infant and Child Mortality , 2019, Nature.